Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 215-221

  Bedi, Brahmchetna ^a   Li, Jau Yi ^a   Grassi, Francesco ^a   Tawfeek, Hesham ^a   Weitzmann, M Neale ^a,b   Pacifici, Roberto ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Bone loss; Bone resorption; Lymphocyte; Parathyroid hormone; T cell

Indexed keywords

ABATACEPT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PARATHYROID HORMONE; T LYMPHOCYTE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; CONFERENCE PAPER; CONTROLLED STUDY; CORTICAL BONE; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOLYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYROID HORMONE METABOLISM;

EID: 77950663905     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05216.x     Document Type: Conference Paper

References (52)

1. Riggs, B.L. & L.J. Melton. 1986. Medical progress: involutional osteoporosis. N. Eng. J. Med. 314: 1676-1684.
2. Grey, A.B., J.P. Stapleton, M.C. Evans & I.R. Reid. 1996. Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 44: 697-702.
3. Potts, J. 1998. Primary hyperparathyroidism. In Metabolic Bone Diseases, 1st edn, Vol.1. L.V.Aa.S. Krane, Ed.: 411-442. Academic Press. San Diego.
4. Parisien, M., D.W. Dempster, E. Shane & J.P. Bilezikian. 2001 Histomorphometric analysis of bone in primary hyperparathyroidism. In The Parathyroids: Basic and Clinical Concepts, pp. 423-436. Academic Press, San Diego.
5. Guo, C.Y., W.E. Thomas, A.W. Al-Dehaimi, et al. 1996. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol.Metab. 81: 3487-3491.
6. Uzawa, T., M. Hori, S. Ejiri & H. Ozawa. 1995. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone. Bone 16: 477-484.
7. Hock, J.M. & I. Gera. 1992. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J. Bone Miner. Res. 7: 65-72.
8. Zhou, H., V. Shen, D.W. Dempster & R. Lindsay. 2001. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and corticalwidth in the estrogen-deficient rat. J. BoneMiner. Res. 16: 1300-1307.
9. Dempster, D.W., M. Parisien, S.J. Silverberg, et al. 1999. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 84: 1562-1566.
10. Iida-Klein, A., S.S. Lu, R. Kapadia, et al. 2005 Shortterm continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice. J. Endocrinol. 186: 549-557.
11. Calvi, L.M., N.A. Sims, J.L. Hunzelman, et al. 2001. Activated parathyroid hormone/parathyroid hormonerelated protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J. Clin. Invest. 107: 277-286.
12. Qin, L., L.J. Raggatt & N.C. Partridge. 2004. Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol. Metab. 15: 60-65.
13. Lee, S.K. & J.A. Lorenzo. 1999. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrowcultures: correlationwith osteoclast-like cell formation. Endocrinology 140: 3552-3561.
14. Ma, Y.L., R.L. Cain, D.L. Halladay, et al. 2001. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142: 4047-4054.
15. Locklin, R.M., S. Khosla, R.T. Turner & B.L. Riggs. 2003. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J. Cell. Biochem. 89: 180-190.
16. Grey, A., M.A. Mitnick, U. Masiukiewicz, et al. 1999. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140: 4683-4690.
17. Greenfield, E.M., S.M. Shaw, S.A. Gornik & M.A. Banks. 1995. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J. Clin. Invest. 96: 1238-1244.
18. O'Brien, C.A., R.L. Jilka,Q. Fu, et al. 2005. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am. J. Physiol. Endocrinol. Metab. 289: E784-E793.
19. Grey, A., M.A.Mitnick, S. Shapses, et al. 1996. Circulating levels of Intreleukin-6 and tumor necrosis factor a are elevated in primary hyperparathyroidism and correlate with markers of bone resorption. J. Clin. Endocrinol. Metab. 81: 3450-3468.
20. McSheehy, P.M.&T.J.Chambers. 1986. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118: 824-828.
21. McSheehy, P.M. & T.J. Chambers. 1986. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 119: 1654-1659.
22. Evely, R.S., A. Bonomo, H.G. Schneider, et al. 1991. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts. J. Bone Miner. Res. 6: 85-93.
23. Weitzmann, M.N. & R. Pacifici. 2005. The role of T lymphocytes in bone metabolism. Immunol. Rev. 208: 154-168.
24. Teitelbaum, S.L. 2004. Postmenopausal osteoporosis, T cells, andimmune dysfunction.Proc.Natl.Acad. Sci.USA 101: 16711-16712.
25. Clowes, J.A., B.L. Riggs & S. Khosla. 2005. The role of the immune system in the pathophysiology of osteoporosis. Immunol. Rev. 208: 207-227.
26. Ahuja, S.S., S. Zhao, T. Bellido, et al. 2003. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144: 1761-1769.
27. McCauley, L.K., T.J. Rosol, J.I.Merryman & C.C. Capen. 1992. Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes. Endocrinology 130: 300-306.
28. Shurtz-Swirski, R., T. Shkolnik & S.M. Shasha. 1995. Parathyroid hormone and the cellular immune system. Nephron 70: 21-24.
29. Perry, H.M., 3rd, J.C. Chappel, E. Bellorin-Font, et al. 1984. Parathyroid hormone receptors in circulating human mononuclear leukocytes. J. Biol. Chem. 259: 5531-5535.
30. Stojceva-Taneva, O., G.Z. Fadda, M. Smogorzewski & S.G. Massry. 1993. Parathyroid hormone increases cytosolic calcium of thymocytes. Nephron 64: 592-599.
31. Geffner, M.E., N. Bersch, A.B. Cortez, et al. 1995. Growth-promoting actions of parathyroid hormone, adrenocorticotrophic hormone, and thyroidstimulating hormone: in vitro studies in normal and pygmy T-lymphoblast cell lines. Pediatr. Res. 37(4 Pt 1): 507-511.
32. Gao,Y., X.Wu,M.Terauchi, J.Y. Li, et al. 2008. T cells potentiate PTH-induced cortical bone loss through CD40L signaling. Cell. Metab. 8: 132-145.
33. Di Rosa, F. & A. Santoni. 2003. Memory T-cell competition for bone marrow seeding. Immunology 108: 296-304.
34. Linsley, P.S., P.M. Wallace, J. Johnson, et al. 1992. Immunosuppression in vivo by a soluble formof theCTLA- 4 T cell activation molecule. Science 257: 792-795.
35. Sayegh,M.H. & L.A. Turka. 1998. The role of T-cell costimulatory activation pathways in transplant rejection. N. Engl. J. Med. 338: 1813-1821.
36. Hogquist, K.A., S.C. Jameson, W.R. Heath, et al. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
37. Barnden, M.J., J. Allison, W.R. Heath & F.R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
38. Grassi, F., G. Tell, M. Robbie-Ryan, et al. 2007. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc. Natl. Acad. Sci. USA 104: 15087-15092.
39. Riggs, B.L. & S. Khosla. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23: 279-302.
40. Cheng, X., J. Li, Y. Lu, et al. 2006. Proximal femoral density and geometry measurements by quantitative computed tomography: Association with hip fracture. Bone 40(1): 169-174.
41. Kong, Y.Y., U. Feige, I. Sarosi, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
42. Taubman, M.A. & T. Kawai. 2001. Involvement of Tlymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit. Rev. Oral. Biol. Med. 12: 125-135.
43. Robey, E.A., F. Ramsdell, J.W.Gordon, et al. 1992. A selfreactive T cell population that is not subject to negative selection. Int. Immunol. 4: 969-974.
44. Tanchot, C. & B. Rocha. 1997. Peripheral selection of T cell repertoires: the role of continuous thymus output. J. Exp. Med. 186: 1099-1106.
45. Grossman, Z. 1993. Cellular tolerance as a dynamic state of the adaptable lymphocyte. Immunol. Rev. 133: 45-73.
46. Ahmed, R. & D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60.
47. Rammensee, H.G., K. Falk & O. Rotzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11: 213-244.
48. Grossman, Z. &W.E. Paul. 2000. Self-tolerance: context dependent tuning of T cell antigen recognition. Semin. Immunol. 12: 197-203; discussion 257-344.
49. Tanchot, C., F.A. Lemonnier, B. Perarnau, et al. 1997. Differential requirements for survival and proliferation ofCD8naive ormemoryTcells. Science. 276: 2057-2062.
50. Kondo, T., I. Cortese, S. Markovic-Plese, et al. 2001. Dendritic cells signal T cells in the absence of exogenous antigen. Nat. Immunol. 2: 932-938.
51. Stefanova, I., J.R. Dorfman & R.N. Germain. 2002. Selfrecognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 420: 429-434.
52. Gao, Y., F. Grassi, M.R. Ryan, et al. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117: 122-132.